Billio, Atto
 Distribuzione geografica
Continente #
EU - Europa 61
NA - Nord America 49
AS - Asia 39
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 158
Nazione #
US - Stati Uniti d'America 48
SE - Svezia 21
IT - Italia 17
CN - Cina 16
SG - Singapore 13
BR - Brasile 7
DE - Germania 5
FI - Finlandia 3
FR - Francia 3
GB - Regno Unito 3
ID - Indonesia 3
IE - Irlanda 3
IN - India 3
RU - Federazione Russa 2
AL - Albania 1
BD - Bangladesh 1
CA - Canada 1
EU - Europa 1
KR - Corea 1
NL - Olanda 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
UY - Uruguay 1
VN - Vietnam 1
Totale 158
Città #
Florence 11
Chandler 9
Singapore 9
Ashburn 6
New York 4
Dublin 3
Düsseldorf 3
Helsinki 3
Jakarta 3
San Mateo 3
Beijing 2
Boston 2
Hyderabad 2
Princeton 2
Rome 2
Bexley 1
Boa Esperança 1
Brooklyn 1
Dearborn 1
Dhaka 1
Hefei 1
Hengyang 1
Izmir 1
Jinan 1
Kunming 1
London 1
Los Angeles 1
Milan 1
Montevideo 1
Moscow 1
Nanchang 1
Nha Trang 1
Ningbo 1
Norwalk 1
Pelotas 1
Porto Alegre 1
Praia Grande 1
Pune 1
Sao Paulo 1
Seattle 1
Seoul 1
Shenyang 1
Springfield 1
Stockholm 1
Suzhou 1
São Paulo 1
Taquarussu 1
Tirana 1
Toronto 1
Vergiate 1
Warner Robins 1
Wilmington 1
Totale 101
Nome #
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 79
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 61
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines 22
Totale 162
Categoria #
all - tutte 992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 2 3 2 0 0 4 1 0 6 2
2022/202328 6 6 3 0 2 5 1 2 2 0 1 0
2023/202437 0 5 5 6 1 10 0 2 0 1 0 7
2024/202557 2 0 5 1 4 6 0 3 6 6 14 10
Totale 162